Liver Transplantation With Tregs at UCSF (LITTMUS-UCSF)

NCT03654040 PHASE1, PHASE2 TERMINATED Results posted

This is a single-center, prospective, open-label, non-randomized clinical trial exploring cellular therapy to facilitate immunosuppression withdrawal in liver transplant recipients.

Details

Lead sponsor	National Institute of Allergy and Infectious Diseases (NIAID)
Phase	PHASE1, PHASE2
Status	TERMINATED
Enrolment	42
Start date	Thu Apr 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Mar 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Liver Transplant

Interventions

• arTreg
• leukapheresis
• cyclophosphamide
• mesna
• everolimus

Countries

United States